| |
| |
|
| Insider
Information: |
Alder Matthias |
| Relationship: |
Chief Executive Office... |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
25,903 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,903 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sucampo Pharmaceuticals, Inc. |
SCMP |
EVP, Gen. Council & Sec. |
2017-06-30 |
4,763 |
2015-06-30 |
0 |
Premium* |
|
|
Gain Therapeutics, Inc. |
GANX |
Chief Executive Office... |
2024-03-26 |
21,140 |
2023-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2024-03-26 |
4 |
D |
$4.06 |
$24,705 |
D/D |
(6,085) |
21,140 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2024-03-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,212 |
27,225 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-12-21 |
4 |
S |
$2.46 |
$507 |
D/D |
(206) |
5,286 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
637 |
5,492 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-12-07 |
4 |
S |
$2.50 |
$4,550 |
D/D |
(1,820) |
4,855 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
825 |
6,675 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-09-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,550 |
5,850 |
0 |
- |
|
| GANX |
Gain Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Gen. Council & Sec. |
• – – |
2017-06-30 |
4 |
A |
$8.93 |
$6,010 |
D/D |
673 |
4,763 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Gen. Council & Sec. |
• – – |
2017-03-31 |
4 |
A |
$9.35 |
$5,993 |
D/D |
641 |
4,224 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus.Dev.&Lic., GC & Sec |
• – – |
2017-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
33,000 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-12-31 |
4 |
A |
$10.46 |
$1,402 |
D/D |
134 |
3,583 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-28 |
4 |
S |
$16.73 |
$417,832 |
D/D |
(24,975) |
3,449 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-28 |
4 |
OE |
$8.33 |
$208,042 |
D/D |
24,975 |
28,424 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-25 |
4 |
S |
$15.88 |
$1,572,517 |
D/D |
(99,025) |
3,449 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-25 |
4 |
OE |
$8.33 |
$824,878 |
D/D |
99,025 |
102,474 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-23 |
4 |
S |
$15.77 |
$410,020 |
D/D |
(26,000) |
3,449 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-11-23 |
4 |
OE |
$8.33 |
$216,580 |
D/D |
26,000 |
29,449 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-09-30 |
4 |
A |
$9.38 |
$5,994 |
D/D |
639 |
3,449 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus. Dev.&Lic, G.C. &Sec. |
• – – |
2016-06-30 |
4 |
A |
$9.32 |
$7,009 |
D/D |
752 |
2,810 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Bus.Dev.&Lic, G.C. &Sec. |
• – – |
2016-03-31 |
4 |
A |
$9.29 |
$5,992 |
D/D |
645 |
2,058 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Business Dev. & Licensing |
• – – |
2015-12-31 |
4 |
A |
$14.70 |
$7,012 |
D/D |
477 |
1,413 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Business Dev. & Licensing |
• – – |
2015-09-30 |
4 |
A |
$14.52 |
$5,997 |
D/D |
413 |
936 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
EVP, Business Dev. & Licensing |
• – – |
2015-06-30 |
4 |
A |
$13.37 |
$6,993 |
D/D |
523 |
523 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
